See every side of every news story
Published loading...Updated

Clinical Trial Sheds Light on Daily CBD Use and Liver Enzymes

UNITED STATES, JUL 7 – A four-week trial found 5% of participants had elevated liver enzymes after low-dose CBD use, raising concerns about liver safety in widespread over-the-counter products.

Summary by MedPage Today
(MedPage Today) -- Daily use of cannabidiol (CBD) at doses commonly reported by consumers was associated with potentially dangerous increases in liver enzymes, a randomized clinical trial found. Among 201 healthy adult participants followed for...

Bias Distribution

  • 67% of the sources lean Left
67% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Monday, July 7, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.